---
figid: PMC3380573__oncotarget-03-371-g001
figtitle: 'Two hits are better than one: targeting both phosphatidylinositol 3-kinase
  and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment'
organisms:
- Homo sapiens
pmcid: PMC3380573
filename: oncotarget-03-371-g001.jpg
figlink: /pmc/articles/PMC3380573/figure/F1/
number: F1
caption: 'TKRs (for example, IGF-1R) stimulate class I PI3K activity. PI3K generates
  PtdIns 3,4,5P3 from PtdIns 4,5,P2. PtdIns 3,4,5P3 attracts to the plasma membrane
  PDK1 which phosphorylates Akt at Thr 308. Full Akt activation requires Ser 473 phosphorylation
  by mTORC2. Active Akt inhibits TSC2 activity through direct phosphorylation. TSC2
  is a GTP-ase activating protein (GAP) that functions in association with TSC1 to
  inactivate the small G protein Rheb. Akt-driven TSC1/TSC2 complex inactivation allows
  Rheb to accumulate in a GTP-bound state. Rheb-GTP then upregulates the protein kinase
  activity of mTORC1. mTORC1 targets p70S6K, 4E-BP1, S6RP, and eIF4B which are critical
  for mRNA translation. However, both mTORC1 and eIF4B are targeted also by the Ras/Raf/MEK/ERK
  pathway. p70S6K controls activation of both PI3K and Ras through an inhibitory loop
  which involves IRS-1/2. Arrows indicate activating events, whereas perpendicular
  lines highlight inhibitory events.Deptor: DEP-domain-containing mTOR interacting
  protein; 4E-BP1: eukaryotic initiation factor 4E-binding protein 1; eIF4B: eukaryotic
  initiation factor 4B; eIF4E: eukaryotic initiation factor 4E; ERK: extracellular
  signal-regulated kinase; IGF-1R: insulin-like growth factor-1 receptor; IRS-1/2:
  insulin receptor substrate 1/2; MEK: mitogen-activated protein kinase kinase; mLST8:
  mammalian Lethal-with-Sec-Thirteen 8; mTOR: mammalian target of rapamycin; mTORC1:
  mTOR complex 1; mTORC2: mTOR complex 2; PDK1: phosphatidylinositol-dependent kinase
  1; PI3K: phosphatidylinositol 3-kinase; PRAS40: proline-rich Akt substrate 40; Protor:
  protein observed with Rictor; PtdIns 4,5P2: PtdIns-4,5-bisphosphate; PtdIns 3,4,5P3:
  PtdIns-3-4,5-trisphosphate; p70S6K: p70S6 kinase; p90RSK: p90 ribosomal S6 kinase;
  Raptor: regulatory associated protein of mTOR; Rheb: Ras homolog enriched in brain;
  Rictor: rapamycin-insensitive companion of mTOR; TRK: receptor tyrosine kinase;
  SIN1: stress-activated protein kinase-interacting protein 1; S6RP: S6 ribosomal
  protein; TSC1: tuberous sclerosis 1; TSC2: tuberous sclerosis 2.'
papertitle: 'Two hits are better than one: targeting both phosphatidylinositol 3-kinase
  and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment.'
reftext: Alberto M. Martelli, et al. Oncotarget. 2012 Apr;3(4):371-394.
year: '2012'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9723752
figid_alias: PMC3380573__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC3380573__F1
ndex: ddd40519-dec3-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3380573__oncotarget-03-371-g001.html
  '@type': Dataset
  description: 'TKRs (for example, IGF-1R) stimulate class I PI3K activity. PI3K generates
    PtdIns 3,4,5P3 from PtdIns 4,5,P2. PtdIns 3,4,5P3 attracts to the plasma membrane
    PDK1 which phosphorylates Akt at Thr 308. Full Akt activation requires Ser 473
    phosphorylation by mTORC2. Active Akt inhibits TSC2 activity through direct phosphorylation.
    TSC2 is a GTP-ase activating protein (GAP) that functions in association with
    TSC1 to inactivate the small G protein Rheb. Akt-driven TSC1/TSC2 complex inactivation
    allows Rheb to accumulate in a GTP-bound state. Rheb-GTP then upregulates the
    protein kinase activity of mTORC1. mTORC1 targets p70S6K, 4E-BP1, S6RP, and eIF4B
    which are critical for mRNA translation. However, both mTORC1 and eIF4B are targeted
    also by the Ras/Raf/MEK/ERK pathway. p70S6K controls activation of both PI3K and
    Ras through an inhibitory loop which involves IRS-1/2. Arrows indicate activating
    events, whereas perpendicular lines highlight inhibitory events.Deptor: DEP-domain-containing
    mTOR interacting protein; 4E-BP1: eukaryotic initiation factor 4E-binding protein
    1; eIF4B: eukaryotic initiation factor 4B; eIF4E: eukaryotic initiation factor
    4E; ERK: extracellular signal-regulated kinase; IGF-1R: insulin-like growth factor-1
    receptor; IRS-1/2: insulin receptor substrate 1/2; MEK: mitogen-activated protein
    kinase kinase; mLST8: mammalian Lethal-with-Sec-Thirteen 8; mTOR: mammalian target
    of rapamycin; mTORC1: mTOR complex 1; mTORC2: mTOR complex 2; PDK1: phosphatidylinositol-dependent
    kinase 1; PI3K: phosphatidylinositol 3-kinase; PRAS40: proline-rich Akt substrate
    40; Protor: protein observed with Rictor; PtdIns 4,5P2: PtdIns-4,5-bisphosphate;
    PtdIns 3,4,5P3: PtdIns-3-4,5-trisphosphate; p70S6K: p70S6 kinase; p90RSK: p90
    ribosomal S6 kinase; Raptor: regulatory associated protein of mTOR; Rheb: Ras
    homolog enriched in brain; Rictor: rapamycin-insensitive companion of mTOR; TRK:
    receptor tyrosine kinase; SIN1: stress-activated protein kinase-interacting protein
    1; S6RP: S6 ribosomal protein; TSC1: tuberous sclerosis 1; TSC2: tuberous sclerosis
    2.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IGF1
  - IGF1R
  - IRS2
  - IRS1
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - CUX1
  - SART3
  - KRAS
  - HRAS
  - NRAS
  - MTOR
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - AKT1
  - AKT2
  - AKT3
  - TSC2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAPKAP1
  - RICTOR
  - MLST8
  - RHEB
  - RHEBP1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - DEPTOR
  - FKBP8
  - EPHB2
  - MAPK1
  - MAPK3
  - RPTOR
  - AKT1S1
  - EIF4B
  - RPS6KA1
  - RPS6KA2
  - RPS6KA3
  - RPS6KA4
  - RPS6KA5
  - RPS6KA6
  - RPS6KB1
  - RPS6KB2
  - Ser
  - Thr
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
